Based on the IDEXX Laboratories Inc stock forecast from 6 analysts, the average analyst target price for IDEXX Laboratories Inc is USD 508.13 over the next 12 months. IDEXX Laboratories Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of IDEXX Laboratories Inc is Slightly Bullish , which is based on 9 positive signals and 6 negative signals. At the last closing, IDEXX Laboratories Inc’s stock price was USD 414.52. IDEXX Laboratories Inc’s stock price has changed by -7.77% over the past week, -13.22% over the past month and -75.86% over the last year.
No recent analyst target price found for IDEXX Laboratories Inc
No recent average analyst rating found for IDEXX Laboratories Inc
Company Overview IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Read Less
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates t...Read More
Frequently Asked Questions About IDEXX Laboratories Inc (IDXX) Stock
Based on ratings from 6 analysts IDEXX Laboratories Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on IDXX's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for IDXX is USD 508.13 over the next 12 months. The maximum analyst target price is USD 596 while the minimum anlayst target price is USD 370.
IDXX stock's Price/Earning ratio is 40.32.
Our analysis grades IDXX stock's Price / Earning ratio at F. This means that IDXX stock's Price/Earning ratio is above 65% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this IDXX may be a overvalued for its sector.
The last closing price of IDXX's stock was USD 414.52.
The most recent market capitalization for IDXX is USD 34.17B.
Based on targets from 6 analysts, the average taret price for IDXX is projected at USD 508.13 over the next 12 months.
This means that IDXX's stock price may go up by +22.58% over the next 12 months.
We can't find any ETFs which contains IDEXX Laboratories Inc's stock.
As per our most recent records IDEXX Laboratories Inc has 11,000 Employees.
IDEXX Laboratories Inc's registered address is One IDEXX Drive, Westbrook, ME, United States, 04092.
You can get more information about it from IDEXX Laboratories Inc's website at https://www.idexx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About IDEXX Laboratories Inc (IDXX) Stock
Based on ratings from 6 analysts IDEXX Laboratories Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on IDXX's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for IDXX is USD 508.13 over the next 12 months. The maximum analyst target price is USD 596 while the minimum anlayst target price is USD 370.
IDXX stock's Price/Earning ratio is 40.32.
Our analysis grades IDXX stock's Price / Earning ratio at F. This means that IDXX stock's Price/Earning ratio is above 65% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this IDXX may be a overvalued for its sector.
The last closing price of IDXX's stock was USD 414.52.
The most recent market capitalization for IDXX is USD 34.17B.
Based on targets from 6 analysts, the average taret price for IDXX is projected at USD 508.13 over the next 12 months.
This means that IDXX's stock price may go up by +22.58% over the next 12 months.
We can't find any ETFs which contains IDEXX Laboratories Inc's stock.
As per our most recent records IDEXX Laboratories Inc has 11,000 Employees.
IDEXX Laboratories Inc's registered address is One IDEXX Drive, Westbrook, ME, United States, 04092.
You can get more information about it from IDEXX Laboratories Inc's website at https://www.idexx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IDXX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
